Northwest Biotherapeutics | NWBO - Ativos





Ativos Alterar Data
Agenus USD 186.46M 40.34M 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Celldex Therapeutics USD 511.25M 71.73M 2026-03
Eisai JPY 1.45T 37.11B 2026-03
Merck USD 128.68B 8.18B 2026-03
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 207.62B 542M 2026-03
Plus Therapeutics USD 19.92M 3.59M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12